Attached files
| file | filename |
|---|---|
| S-1/A - AMENDED REGISTRATION STATEMENT - SOLIGENIX, INC. | fs12013a4_soligenix.htm |
| EX-5.1 - LEGAL OPINION - SOLIGENIX, INC. | fs12013a4ex5i_soligenix.htm |
| EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - SOLIGENIX, INC. | fs12013a4ex23i_soligenix.htm |
EXHIBIT 21.1
SUBSIDIARIES OF SOLIGENIX, INC.
The following represents a list of Soligenix, Inc.’s subsidiaries:
|
Name
|
Ownership
|
State of Incorporation
|
|||||
|
Enteron Pharmaceuticals, Inc.
|
100.00
|
%
|
Delaware
|
||||
|
Orasomal Technologies Inc.
|
75.30
|
%
|
Delaware
|
||||
|
BioDefense Corp.
|
100.00
|
%
|
Delaware
|
||||
|
Soligenix BioPharma Canada Incorporated
|
100.00
|
%
|
Canada
|
||||
|
Soligenix UK Limited
|
100.00
|
%
|
United Kingdom
|
||||